FDA Sensitivity Assertions
| Drug | Indication | Recommendation | FDA Source | Link |
|---|---|---|---|---|
| Pembrolizumab | Solid tumors, Colorectal cancer | INDICATED | FDA Label | |
| Dostarlimab | Solid tumors, Colorectal cancer | INDICATED | FDA Label | |
| Nivolumab | Solid tumors, Colorectal cancer | INDICATED | FDA Label | |
| Ipilimumab | Solid tumors, Colorectal cancer | INDICATED | FDA Label | |
| Lenvatinib | Solid tumors, Colorectal cancer | INDICATED | FDA Label |